Ngā hua rapu kaituhi :: APM

1

Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma mā Chi-Jung Wu, Pei‐Chang Lee, Ya‐Wen Hung, Chieh-Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria mā Ya-Wen Hung, I-Cheng Lee, Chen-Ta Chi, Rheun‐Chuan Lee, Chien-An Liu, Nai‐Chi Chiu, Hsuen-En Hwang, Yee Chao, Ming-Chih Hou, Yi‐Hsiang Huang

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy mā Hsien-Chen Mon, Pei‐Chang Lee, Yi‐Ping Hung, Ya‐Wen Hung, Chi-Jung Wu, Chieh-Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma mā Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung, Chieh Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Yu‐Lun Kuo, Shih-Hsuan Chou, Jiing‐Chyuan Luo, Ming‐Chih Hou, Yi‐Hsiang Huang

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: